tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Clover Health Holds Virtual Annual Stockholders Meeting

Story Highlights
  • Clover Health held its Annual Meeting on June 10, 2025, to vote on three proposals.
  • Stockholders elected directors, approved executive compensation, and ratified Ernst & Young LLP.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Clover Health Holds Virtual Annual Stockholders Meeting

Elevate Your Investing Strategy:

Clover Health Investments ( (CLOV) ) has issued an update.

On June 10, 2025, Clover Health Investments held its Annual Meeting of Stockholders virtually, where three proposals were voted on. The stockholders elected Dr. Anna U. Loengard and William G. Robinson, Jr. as Class I directors, approved the compensation of the Named Executive Officers for 2024, and ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. These decisions reflect the company’s ongoing governance and operational strategies, potentially impacting its future direction and stakeholder confidence.

The most recent analyst rating on (CLOV) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.

Spark’s Take on CLOV Stock

According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.

Clover Health’s stock score is influenced by its ongoing financial challenges, despite positive developments in operational metrics and an encouraging earnings call. The financial performance remains a significant concern due to negative margins and revenue decline. Technical indicators signal potential weakness, while valuation remains unattractive due to losses. The company’s achievements in profitability and membership growth offer potential for future improvement.

To see Spark’s full report on CLOV stock, click here.

More about Clover Health Investments

Clover Health Investments, Corp. operates in the healthcare industry, focusing on providing Medicare Advantage plans. The company leverages technology to offer a more efficient healthcare experience and aims to improve health outcomes while reducing costs.

Average Trading Volume: 5,676,441

Technical Sentiment Signal: Sell

Current Market Cap: $1.52B

Find detailed analytics on CLOV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1